%A ZHAO Xiang-Fei, NIE Qing, KANG Jing-Bo %T Strategy of anti-angiogenesis and antiangiogenic drugs in NSCLC %0 Journal Article %D 2012 %J Journal of International Oncology %R %P 916-920 %V 39 %N 12 %U {https://gjzlx.sdfmu.edu.cn/CN/abstract/article_8949.shtml} %8 2012-12-08 %X Development and metastasis of NSCLC are closely related to angiogenesis. Several distinct groups of vascular – targeted therapies have evolved: anti-VEGF monoclonal antibody , Small Molecules, Vascular disrupting agents，Endothelial cell growth inhibitor，et al. Antiangiogenic treat could make longer survival than conventional treatment. The strategy of anti-angiogenic drugs combined conventional treatment is are being studied.